Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Transfusion Medicine (Oxford, England)
|
December 5, 2003
Exploitation of stem cell plasticity
E Martin-Rendon, S M Watt
Current Opinion in Molecular Therapeutics
|
November 9, 2001
Lentiviral vectors for the treatment of neurodegenerative diseases
E Martin-Rendon, M Azzouz, N D Mazarakis
Transfusion Medicine (Oxford, England)
|
August 27, 2009
Stem cell-related therapies for vascular diseases
E Martin-Rendon, J A Snowden, S M Watt
Transfusion Medicine (Oxford, England)
|
September 15, 2009
Clinical stem cell therapies for severe autoimmune diseases
J A Snowden, E Martin-Rendon, S M Watt
Current Genetics
|
December 1, 1993
Isolation of a mutant allele that deregulates the threonine biosynthesis in Saccharomyces cerevisiae
E Martin-Rendon, M J Farfán, C Ramos, et al.
Yeast (Chichester, England)
|
June 28, 2000
Possible regulatory function of the Saccharomyces cerevisiae Ty1 retrotransposon core protein
J F Roth, S M Kingsman, A J Kingsman, et al.
Clinical Pharmacology and Therapeutics
|
January 29, 2016
Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews
S A Fisher, C Doree, D P Taggart, et al.
Vox Sanguinis
|
June 19, 2008
5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies
E Martin-Rendon, D Sweeney, F Lu, et al.
Molecular Microbiology
|
December 1, 1996
Identification of proteolytic cleavage sites within the gag-analogue protein of Ty1 virus-like particles
E Martin-Rendon, D W Hurd, G Marfany, et al.
The Journal of Biological Chemistry
|
April 24, 2001
Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain
M A Benson, S E Newey, E Martin-Rendon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Transfusion Medicine (Oxford, England)
|
December 5, 2003
Exploitation of stem cell plasticity
E Martin-Rendon, S M Watt
Current Opinion in Molecular Therapeutics
|
November 9, 2001
Lentiviral vectors for the treatment of neurodegenerative diseases
E Martin-Rendon, M Azzouz, N D Mazarakis
Transfusion Medicine (Oxford, England)
|
August 27, 2009
Stem cell-related therapies for vascular diseases
E Martin-Rendon, J A Snowden, S M Watt
Transfusion Medicine (Oxford, England)
|
September 15, 2009
Clinical stem cell therapies for severe autoimmune diseases
J A Snowden, E Martin-Rendon, S M Watt
Current Genetics
|
December 1, 1993
Isolation of a mutant allele that deregulates the threonine biosynthesis in Saccharomyces cerevisiae
E Martin-Rendon, M J Farfán, C Ramos, et al.
Yeast (Chichester, England)
|
June 28, 2000
Possible regulatory function of the Saccharomyces cerevisiae Ty1 retrotransposon core protein
J F Roth, S M Kingsman, A J Kingsman, et al.
Clinical Pharmacology and Therapeutics
|
January 29, 2016
Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews
S A Fisher, C Doree, D P Taggart, et al.
Vox Sanguinis
|
June 19, 2008
5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies
E Martin-Rendon, D Sweeney, F Lu, et al.
Molecular Microbiology
|
December 1, 1996
Identification of proteolytic cleavage sites within the gag-analogue protein of Ty1 virus-like particles
E Martin-Rendon, D W Hurd, G Marfany, et al.
The Journal of Biological Chemistry
|
April 24, 2001
Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain
M A Benson, S E Newey, E Martin-Rendon, et al.
Page
of 2